Clinical trial NIR-DT-301
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors (DTs)/Aggressive Fibromatosis (AF)
| Cancers | |
|---|---|
| Organ | Soft tissue |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | SpringWorks Therapeutics |
| EudraCT Identifier | 2018-001991-39 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03785964 |
| Inclusion criteria | RECIST v1.1 |
| Last update |